Results 61 to 70 of about 36,851 (264)
Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions
Allergy, EarlyView.ABSTRACT Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases worldwide. The clinical presentation of AD is heterogeneous and is characterized by a relapsing and remitting course. Most patients suffer from mild AD while approximately 5% to 20% experience severe disease activity, which often requires systemic treatment ...
Marjolein S. de Bruin‐Weller +9 more
wiley +1 more source
Iranian Journal of Allergy, Asthma and Immunology, 2018 Preparation of the indigenous varicella zoster vaccine could significantly reduce the disease burden of varicella zoster virus especially in immunosuppressed children.
Fatemeh Esna-Ashari +3 more
doaj +1 more source
Bioethics, EarlyView.ABSTRACT This article challenges the claim that conscientious refusal and conscientious provision in healthcare are mutually exclusive and thus asymmetrical. While US law protects healthcare providers who refuse to perform medical services on moral or religious grounds, it offers no equivalent protections to those who feel morally compelled to provide ...
Tzofit Ofengenden
wiley +1 more source
Varicella epidemiology in Latin America and the Caribbean
Expert Review of Vaccines, 2018 Introduction: The Latin American Society of Pediatric Infectious Diseases (SLIPE), with the support of the Americas Health Foundation (AHF), has developed a position paper on varicella prevention in Latin America and Caribbean countries (LAC).
Maria L. Ávila-Agüero +13 more
doaj +1 more source
Study of the Clinical Patterns in Varicella in a Tertiary Hospital at Coastal Karnataka [PDF]
, 2011 Context: There are very few studies regarding the clinical patterns and manifestations of a very common viral infection, Varicella, especially from south India.
Girish, PN +3 more
core
Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention Strategies
European Journal of Haematology, EarlyView.ABSTRACT Infections remain a leading cause of morbidity and mortality in patients with chronic lymphocytic leukemia (CLL), reflecting both intrinsic immune dysfunction and therapy‐related immunosuppression. The pathogenesis of immunodeficiency in CLL is multifactorial: neoplastic B cells impair humoral immunity, T cells are functionally exhausted, and ...
Enrica Antonia Martino +10 more
wiley +1 more source
Live Attenuated Varicella Vaccine
The Journal of Pediatrics, 1984 Live attenuated varicella vaccine will in all probability soon be licensed in the United States for immunization of healthy children and adults and certain immunocompromised children. This vaccine can be expected to protect susceptibles from varicella (or to modify it) in those subsequently exposed to the wild virus.
openaire +6 more sources
Valuing the benefit of varicella vaccination: comparison of willingness to pay and quality-adjusted life-years [PDF]
, 2004 Vaccination is different from most health interventions because it is preventative, it protects against infectious disease (leading to knock-on effects), the diseases it prevents are usually acute and self-limiting, and most vaccines are given to ...
Brisson, M., Edmunds, J.
core
European Journal of Haematology, EarlyView.ABSTRACT Allogeneic hematopoietic stem cell transplantation (HSCT) is increasingly used to treat malignant and non‐malignant diseases. Following allogeneic HSCT, patients are particularly vulnerable to vaccine‐preventable diseases (VPD) because conditioning depletes immune cells, including memory cells.
Hélène Buvelot +3 more
wiley +1 more source
A fresh look at varicella vaccination
Human Vaccines & ImmunotherapeuticsThe varicella vaccine is a live attenuated varicella zoster virus (VZV), first produced by Michiaki Takahashi (1974). Subsequent development of the fluorescent antibody to VZV membrane antigen test (FAMA), an immune correlate, permitted vaccine efficacy ...
Anne A. Gershon, Michael D. Gershon
doaj +1 more source